“…ANN proved to be very useful in the current analysis as it allowed us to assess the role of potential predictors of CMCT and MEP at month 12 as continuous outcomes, without the possible constraints of parametric models (e.g., normal distribution of the outcome, etc.). To note, ANN had been successfully used in other medical fields [Mecocci, 2002;Grossi, 2011;Azarkhish et al, 2012;etc. ] and, in neurology, in particular [Mecocci, 2002;Shanthi et al, 2009; for a recent overview see Atanassova & Dimitrov, 2011].…”